Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Artec, Inc. (Bulls Board) -- Ignore unavailable to you. Want to Upgrade?

To: rmarc who wrote (20)	12/8/2005 11:35:07 AM
From: donpat	Read Replies (1) \| Respond to of 51

I like things that sound good! They sometimes lead to the bottom line looking good. ;-) Whatever - but Chung is at the top of the WHO, had Shapiro doing FDA type testing that apparently was favorable and now we have HTDS making life tough for us and Tubercin which they will never get - either as a license or as a product - well, not legally. Shapiro would be wise to switch to Artec and get with the winner. HTDS is going nowhere with Tubercin in any way, shape or form. The only place HTDS will frequent is the court room.